drugset / Trial / NCT02741154

Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI

NCT02741154

Phase 4 Completed 50 enrolled Minia University
RandomizedParallel-groupSingle-blindTreatment

Summary

study the effect of aromataze inhibitor induction together with short stimulation protocol by gonadotrphin releasing hormon antagonist in cases that expected to be poor responder before ICSI

Timeline

Start
2016-08-12
Primary completion
2017-08-24
Completion
2017-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 2.5 mg
Background HCG Unknown 10000 iu
Background HMG Unknown 300 iu
Background Leuprolide Other / unclassified 0.1 ml

Indications